Detection of methytation of the promoter region of the MAL and CADM1 genes by pyrosequencing in Cervical carcinoma

Neuroendocrinology Letters

Volumn 35, Issue 7, 2014, Pages 619-623

  Mersakova, Sandra ^a,b   Visnovsky, Jozef ^a   Holubekova, Veronika ^b   Nachajova, Marcela ^a   Kudela, Erik ^a   Danko, Jan ^a   Lasabova, Zora ^b  

^a Martinska Fakultna Nemocnica   (Slovakia)

^b University Hospital in Martin   (Slovakia)

Author keywords

CADM1; Cervical cancer; MAL; Methylation; Pyrosequencing

Indexed keywords

DNA; CADM1 PROTEIN, HUMAN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN; MAL PROTEIN, HUMAN; MYELIN AND LYMPHOCYTE PROTEIN;

ARTICLE; CADM1 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DYSPLASIA; FEMALE; GENE; HUMAN; HUMAN CELL; MAL GENE; PROMOTER REGION; PYROSEQUENCING; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; CONTROLLED CLINICAL TRIAL; DEVICES; DNA SEQUENCE; GENETICS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROCEDURES; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

CELL ADHESION MOLECULES; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; IMMUNOGLOBULINS; MYELIN AND LYMPHOCYTE-ASSOCIATED PROTEOLIPID PROTEINS; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84924533096     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Arbyn M, Castellsagué X, De Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J (2011). Worldwide burden of cervical cancer in 2008. Ann Oncol. 22(12):2675-2686.
2. Balch C, Fang F, Matei DE, Huang TH, Nephew KP (2009). Minireview: epigenetic changes in ovarian cancer. Endocrinology. 150(9):4003-4011.
3. Bierkens M, Hesselink AT, Meijer CJ, Heideman DA, Wisman GB, Van Der Zee AG, et al. (2013). CADM1 and MAL promoter methylation levels in hrHPV-positive cervicalscrapes increase proportional to degree and duration of underlying cervical disease. Int J Cancer. 133:1293-1299.
4. Ferlay J. et al. (2008). Estimates of worldwide burden of cancer. GLOBOCAN.
5. Hausen et al. (1999). Papillomaviruses in human cancers. Proc Assoc Am Physicians. 111:581-587.
6. Meijer et al. (2013). MAL and CADM1 promoter methylation a molecular diagnostic marker for HPV-induced invasive cervical cancers and their high-grade precursor lesions. EUROPEAN PATENT SPECIFICATION EP 2 283 154 B1.
7. Overmeer RM, Louwers JA, Meijer CJ, Van Kemenade FJ, Hesselink AT, Daalmeijer NF, et al. (2010). Combined CADM1 and MAL promoter methylation analysis to detect (pre-) malignant cervical lesions in high-risk HPV-positive women. Int J Cancer 129:2218-25.
8. Portela A, Esteller M (2010). Epigenetic modifications and human disease. Nat Biotechnol. 28:1057-68.
9. Robertson et al. (2005). DNA methylation and human disease. Nat Rev Genet. 6:597-610.
10. Snijders PJ, Steenbergen RD, Heideman DA et al. (2006). HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 208:152-164.
11. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. (2002). The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 287(16):2114-2119.
12. Sung et al. (2013.) Methylation markers for diagnosis of cervical cancer. Patent application publication.
13. Takai D, Jones PA (2002). Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proceedings of the National Academy of Sciences of the United States of America. 99(6):3740-3745.
14. Vasiljevic et al. (2014). Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women. Gynecologic Oncology. 132:709-714.
15. Wajed S A, Laird PW, De Meester TR (2001). DNA Methylation: An Alternative Pathway to Cancer. Annals of Surgery. 234(1):10-20.